Efficacy Study of Osimertinib in Treatment-naïve Patients With EGFR Mutant NSCLC According to TP53 Mutational Status.
Clinical trial NCT05785208 · UNKNOWN
Trial details
- NCT number
- NCT05785208
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-28
- Primary completion
- 2024-02-28
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.